SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-157423
Filing Date
2022-05-23
Accepted
2022-05-23 16:01:37
Documents
99
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d355899d10q.htm   iXBRL 10-Q 1608010
2 EX-31.1 d355899dex311.htm EX-31.1 8671
3 EX-31.2 d355899dex312.htm EX-31.2 10071
4 EX-32.1 d355899dex321.htm EX-32.1 7309
  Complete submission text file 0001193125-22-157423.txt   9174071

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20220331.xsd EX-101.SCH 84306
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ffntf-20220331_cal.xml EX-101.CAL 61006
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ffntf-20220331_def.xml EX-101.DEF 348162
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20220331_lab.xml EX-101.LAB 599593
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20220331_pre.xml EX-101.PRE 501137
93 EXTRACTED XBRL INSTANCE DOCUMENT d355899d10q_htm.xml XML 1717032
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 22951501
SIC: 2833 Medicinal Chemicals & Botanical Products